A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
NCT02619604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-02-15
Summary
This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).
Conditions
Interventions
- OTHER
-
Education Intervention
Education interventions will be delivered sporadically within the 6-month window between the time the clinician completes the pre-survey and when he/she completes the post-survey. Interventions consist of e-brief publications, teleconferences with project faculty, and evidence based resources.
Sponsors & Collaborators
-
Med-IQ
collaborator INDUSTRY - collaborator INDUSTRY
-
Genentech, Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Linda Sutton, MD · Duke University
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study
NCT03231579 ·Status: COMPLETED
-
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
NCT05082519 ·Status: RECRUITING ·Phase: PHASE2
-
Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
NCT00514696 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT07030400 ·Status: RECRUITING
-
A Study in Participants With Acute Leukemia
NCT01214603 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
NCT03075969 ·Status: UNKNOWN
-
A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG
NCT06792994 ·Status: RECRUITING
-
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
NCT00267059 ·Status: COMPLETED ·Phase: PHASE2
-
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
NCT01649791 ·Status: TERMINATED ·Phase: NA
-
Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia
NCT00917540 ·Status: UNKNOWN
-
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
NCT01145469 ·Status: COMPLETED
-
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
NCT01089907 ·Status: UNKNOWN
-
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
NCT05899543 ·Status: NOT_YET_RECRUITING
-
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
NCT06762431 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
NCT05007860 ·Status: COMPLETED
-
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
NCT01750567 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
NCT01642069 ·Status: COMPLETED
-
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
NCT01380587 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
NCT01625143 ·Status: COMPLETED
-
Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
NCT00836043 ·Status: TERMINATED
-
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
NCT00860457 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia
NCT01148927 ·Status: COMPLETED
-
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01295476 ·Status: COMPLETED
-
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
NCT05672355 ·Status: SUSPENDED ·Phase: PHASE2
-
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
NCT04016636 ·Status: COMPLETED